Interim Report First Quarter 2020
Interim ReportFirst Quarter 2020
April 23, 2020 Interim Report Q1 20202
This presentation may contain forward-looking statements. Such
statements are based on our current expectations and are subject
to certain risks and uncertainties that could negatively affect our
business. Please read our most recent annual and sustainability
report for a better understanding of these risks and uncertainties.
Q1 2020 vs Q1 2019
Summary
Interim Report Q1 20203 April 23, 2020
1) Net sales which excludes exchange rate effects, acquisitions and divestments2) Excluding items affecting comparability
▪ Strong increase in net sales and earnings
─ Partially a consequence of COVID-19
─ Sharp sales increase in March of 19.7%
─ Strong underlying business performance
▪ Higher volumes, better mix and cost savings
▪ Lower prices mainly in Consumer Tissue
▪ Lower raw material and energy costs
▪ Increased sales and marketing costs
Adjusted
EBITA Margin2)Net Sales
Adjusted
EBITA2)
Organic
Net Sales1)
x%
Adjusted
ROCE2)
Adjusted
ROE2)
Operating
Cash Flow
Earnings
per Share
SEK
33,712m
+10.0%
+7.8%
SEK
5,333m
+67%
15.8%
+540bps
18.4%
+710bps
SEK
4.61
+85%
SEK
4,481m
+108%
22.4%
+780bps
Increased Sales and Profitability
28,155
27,17828,664
28,02029,721
29,647
31,112
30,65632,068
32,565
33,686 33,712
-0.1%
+1.8% +1.8%
+3.4%
+2.3%
+1.6%
+3.3%
+4.3%+3.9%
+5.9%
+3.6%
7.8%
-2,00%
0,00%
2,00%
4,00%
6,00%
8,00%
10,00%
25000
27000
29000
31000
33000
35000
37000
39000
Q22017
Q32017
Q42017
Q12018
Q22018
Q32018
Q42018
Q12019
Q22019
Q32019
Q42019
Q12020
Net Sales, SEKm Organic Net Sales Growth, %
Interim Report Q1 2020April 23, 20204
3,437 3,432
3,619
3,119
3,349
3,016
3,451
3,190
3,732
4,176
4,742
5,333
12.2%
12.6% 12.6%
11.1%11.3%
10.2%
11.1%
10.4%
11.6%
12.8%
14.1%
15.8%
7%
8%
9%
10%
11%
12%
13%
14%
15%
16%
17%
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
Q22017
Q32017
Q42017
Q12018
Q22018
Q32018
Q42018
Q12019
Q22019
Q32019
Q42019
Q12020
Adjusted EBITA, SEKm Adjusted EBITA margin, %
Adjusted EBITA and EBITA margin2)Net Sales and Organic Net Sales Growth1)
1) Organic net sales which excludes exchange rate effects, acquisitions and divestments2) Excluding items affecting comparability
Net Sales
Interim Report Q1 2020April 23, 20205
Q1 2020 vs Q1 2019
Net SalesQ1 2019
Volume Price/Mix Divestment Currency Net SalesQ1 2020
+5.9%
+2.5%+1.9%
+10.0%
Organic Net Sales1) +7.8%
SEK 30,656m
SEK 33,712m
1) Net sales which excludes exchange rate effects, acquisitions and divestments
-0.3%
Adjusted EBITA Margin1)
Q1 2020 vs Q1 2019
Interim Report Q1 2020April 23, 20206
1) Excluding items affecting comparability
▪ Impact from lower raw material
and energy costs +470 bps
▪COGS savings of SEK 260m
10.4%
15.8%+560 bps -30 bps +10 bps
Adjusted EBITA Margin
Q1 2019
Impact Gross
Profit Margin
A&P SG&A
(excl A&P)
Adjusted EBITA Margin
Q1 2020
+540 bps
Raw Material Development
Interim Report Q1 2020April 23, 20207
75
100
125
150
Polypropylene, EUR Propylene, EUR
75
100
125
150
Fluff NBSK EUCA
40
60
80
100
120
140
SOP US SOP EU
Source: Fastmarkets RISI, Fastmarkets FOEX, VDP, Macrobond, Epexspot, ICIS
Oil-based Raw Materials2)
Market Pulp in USD, Europe Paper for Recycling1)
Index 100 = July 2017 1) Sorted Office Paper. Index in local currencies. EU refers to Germany 2) Polypropylene major feedstock of non-woven material, Propylene major feedstock of SAP material 3) Electricity Germany. Natural Gas, TTF Index
50
75
100
125
150
175
200
Electricity, EUR Natural Gas, EUR
Energy Prices3)
InnovationsQ1 2020
April 23, 2020 Interim Report Q1 20208
Manufacturing
of surgical and
face masks for
health and
elderly care as
well as for our
employees
Personal Care
▪ Organic net sales increased 8.8%
─ Volume +6.9% and price/mix +1.9%
─ Partially impacted by COVID-19
─ Sharp sales increase in March of 17.0%
▪ Higher volumes, higher prices, better mix and cost savings
▪ Lower raw material costs
▪ Higher distribution costs
▪ Increased sales and marketing costs and MDR
▪ Acquisitions of ABIGO Medical and Novioscan
Q1 2020 vs Q1 2019
Interim Report Q1 2020April 23, 20209
SEK 12,669mSEK 11,535m
Q1 2019 Q1 2020
SEK 2,039m
SEK 1,540m
Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)
+32%+9.8% 13.4%
16.1%
+8.8%
Total Mature
Markets
Incontinence
Products
By Region By Product Segment
Emerging
Markets
+7.5%
+11.8%
+5.6%
+15.5%
Baby
Care
Feminine
Care
% of Personal
Care Net Sales: 64% 36% 46% 17% 18%19%
-0.1%
+11.5%
Medical
Solutions
Organic Net Sales
1) Excluding items affecting comparability
Q1 2019 Q1 2020 Q1 2019 Q1 2020
+270
bps
Consumer Tissue
▪ Organic net sales increased 4.3%
─ Volume +3.7% and price/mix +0.6%
─ Partially impacted by COVID-19
─ Sharp sales increase in March of 19.5%
▪ Higher volumes, positive mix, cost savings but lower prices
▪ Lower raw material and energy costs
▪ Higher distribution costs
Q1 2020 vs Q1 2019
Interim Report Q1 2020April 23, 202010
SEK 13,080m
SEK 12,248m
SEK 2,092m
SEK 1,069m
Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)
+6.8% +730
bps8.7%
16.0%
Q1 2019 Q1 2020
+4.3%
Total Mature
Markets
Organic Net Sales By Region
Emerging
Markets
+8.9%
% of Consumer
Tissue Net Sales: 57% 43%
-0.8%
+96%
1) Excluding items affecting comparability
Q1 2019 Q1 2020 Q1 2019 Q1 2020
Professional Hygiene
▪ Organic net sales increased 12.2%
─ Volume +7.9% and price/mix +4.3%
─ Partially impacted by COVID-19
─ Sharp sales increase in March of 24.5%
▪ Higher volumes, better mix, higher prices and cost savings
▪ Lower raw material and energy costs
▪ Higher distribution costs
▪ Increased sales and marketing costs
Q1 2020 vs Q1 2019
Interim Report Q1 2020April 23, 202011
Q1 2019 Q1 2020
SEK 7,957m
SEK 6,867m
Net Sales Adjusted EBITA1) Adjusted EBITA Margin1)
+88%+15.9%
+670
bps
17.5%
10.8%SEK 741m
SEK 1,393m
Q1 2019 Q1 2020
+3.0%
+15.2%
% of Professional
Hygiene Net Sales:
+0.8%
Total Mature
Markets
Emerging
Markets
82% 18%
Organic Net Sales By Region
1) Excluding items affecting comparability
Q1 2019 Q1 2020 Q1 2019 Q1 2020
+12.2%
COVID-19
Interim Report Q1 2020April 23, 202012
▪ Leading hygiene and health solutions
▪ Educational efforts on importance of hand hygiene
▪ Manufacturing of surgical and face masks in Sweden,
US and Mexico for health and elderly care as well as
for our employees
▪ Supporting NGOs, local initiatives and WHO Covid-
19 Solidarity Response Fund
▪ Positive feedback from customers appreciating our
support, service and delivery reliability
Secure
Business
Success
Contribute
to Society
Care for
Our People
SummaryQ1 2020
Interim Report Q1 2020April 23, 202013
▪ Strong increase in net sales and earnings
─ Partially a consequence of COVID-19. Sales in
future quarters will be adversely impacted
─ Strong underlying business performance
▪ Acquisitions of ABIGO Medical and Novioscan
▪ Increasing importance of hygiene and health